Clinical trial
Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal…
NCT00112632 · Technical University of Munich, Other · Completed
Key facts
| NCT number | NCT00112632 |
|---|---|
| Title | Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor |
| Official title | Open-Label Trial of Neoadjuvant Imatinib Mesylate (Glivec) in Patients With Locally Advanced Malignant Gastrointestinal Stromal Tumors (GIST) Expressing c-Kit or Platelet-Derived Growth Factor Receptor-alpha |
| Lead sponsor | Technical University of Munich, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gastrointestinal Stromal Tumor |
| Intervention type | Drug, Procedure |
| Interventions | imatinib mesylate, conventional surgery, neoadjuvant therapy |
| Enrollment | 40 |
| Start date | Feb 1, 2005 |
| First posted | Jun 3, 2005 |
| Last update posted | Mar 8, 2012 |
| Countries | Austria, Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: